Advancements could enhance perceptual capabilities in robotics. Artificially engineered biological processes, such as ...

Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, has hired David W. Allen, a long-time food industry executive, as its new Chief Operating Officer. Mr. Allen ...

Beer might seem like a timeless and quintessential pairing with hot wings, but you might want to rethink sipping an IPA with ...

Estimates say bird numbers have dropped by as much as 16% in the UK in the past 50 years, which is why gardeners are being ...

Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects ...

A large research team led by nanotechnologist Roy van der Meel rebuilt the body's own proteins and fats into nano-delivery ...

A large research team led by nanotechnologist Roy van der Meel rebuild the body's own proteins and fats into nano delivery ...

Court Square Capital Partners ("Court Square"), a leading middle-market private equity firm, and WindRose Health Investors ("WindRose"), the New York-based healthcare private equity firm, today ...

Previously, the drugs were able to be prescribed through an email chat, from questionnaires or by people sending in photos of ...

Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...

MSCs from mice deficient for the IFNγ receptor IFNγR1 do not have immunosuppressive activity, which highlights the crucial role of IFNγ in this model 43. However, inhibition of any one of these ...